Literature DB >> 12860855

The current cost of angina pectoris to the National Health Service in the UK.

S Stewart1, N F Murphy, N Murphy, A Walker, A McGuire, J J V McMurray.   

Abstract

OBJECTIVE: To calculate the cost of angina pectoris to the UK National Health Service (NHS) in the year 2000.
METHODS: Calculation of the cost of hospital admissions, revascularisation procedures, hospital outpatient consultations, general practice (GP) consultations, and prescribed drug treatment.
RESULTS: 634 000 individuals (1.1% of the UK population) consulted GPs 2.35 million times, costing pound 60.5 million. They required 16.0 million prescriptions (cost pound 80.7 million) and 254 000 hospital outpatient referrals (cost pound 30.4 million). There were 149 000 hospital admissions, 117 000 coronary angiograms, 21 400 coronary artery bypass operations, 17 700 percutaneous coronary interventions, and 516 000 outpatient visits, at a cost of pound 208.4 million, pound 69.9 million, pound 106.2 million, pound 60.7 million, and pound 52.2 million, respectively. The direct cost of angina was therefore pound 669 million (1.3% of total NHS expenditure), with hospital bed occupancy and procedures accounting for 32% and 35% of this total, respectively.
CONCLUSIONS: Angina is a common and costly public health problem. It consumed over 1% of all NHS expenditure in the year 2000, mainly because of hospital bed occupancy and revascularisation procedures. This is likely to be a conservative estimate of its true cost.

Entities:  

Mesh:

Year:  2003        PMID: 12860855      PMCID: PMC1767798          DOI: 10.1136/heart.89.8.848

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  17 in total

Review 1.  Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.

Authors:  C Meads; C Cummins; K Jolly; A Stevens; A Burls; C Hyde
Journal:  Health Technol Assess       Date:  2000       Impact factor: 4.014

2.  Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.

Authors:  W Maier; S Windecker; E Boersma; B Meier
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

3.  Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: a prospective study of all 9890 consecutive patients operated on in Scotland over a two year period.

Authors:  J P Pell; D Walsh; J Norrie; G Berg; A D Colquhoun; K Davidson; H Eteiba; A Faichney; A Flapan; K J Hogg; R R Jeffrey; K Jennings; J McArthur; P Mankad; K Oldroyd; A C Pell; I R Starkey
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

4.  The diagnosis of ischaemic heart pain and intermittent claudication in field surveys.

Authors:  G A ROSE
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

5.  An economic evaluation of asthma in the United States.

Authors:  K B Weiss; P J Gergen; T A Hodgson
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

6.  Variability of angina symptoms and the risk of major ischemic heart disease events.

Authors:  F C Lampe; P H Whincup; A G Shaper; S G Wannamethee; M Walker; S Ebrahim
Journal:  Am J Epidemiol       Date:  2001-06-15       Impact factor: 4.897

7.  Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study.

Authors:  S Capewell; K MacIntyre; S Stewart; J W Chalmers; J Boyd; A Finlayson; A Redpath; J P Pell; J J McMurray
Journal:  Lancet       Date:  2001-10-13       Impact factor: 79.321

8.  Prevalence of ischaemic heart disease in middle aged British men.

Authors:  A G Shaper; D G Cook; M Walker; P W Macfarlane
Journal:  Br Heart J       Date:  1984-06

9.  Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK.

Authors:  S Stewart; N F Murphy; N Murphy; A Walker; A McGuire; J J V McMurray
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more
  24 in total

1.  Impact of nicorandil in angina: subgroup analyses.

Authors: 
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

Review 2.  Investigation and management of chest pain.

Authors:  Kevin F Fox
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

Review 3.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  How effective are rapid access chest pain clinics? Prognosis of incident angina and non-cardiac chest pain in 8762 consecutive patients.

Authors:  N Sekhri; G S Feder; C Junghans; H Hemingway; A D Timmis
Journal:  Heart       Date:  2006-06-21       Impact factor: 5.994

5.  Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.

Authors:  Michael McGillion; Philippe L L'Allier; Heather Arthur; Judy Watt-Watson; Nelson Svorkdal; Tammy Cosman; Paul Taenzer; Anil Nigam; Louise Malysh
Journal:  Can J Cardiol       Date:  2009-07       Impact factor: 5.223

Review 6.  A review of the cost of cardiovascular disease.

Authors:  Jean-Eric Tarride; Morgan Lim; Marie DesMeules; Wei Luo; Natasha Burke; Daria O'Reilly; James Bowen; Ron Goeree
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

7.  Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort study.

Authors:  Jaskaran S Kang; Maria C Bennell; Feng Qiu; Merril L Knudtson; Peter C Austin; Dennis T Ko; Harindra C Wijeysundera
Journal:  CMAJ Open       Date:  2016-08-08

8.  Health Resource Utilization and Direct Costs Associated with Angina for Patients with Coronary Artery Disease in a US Managed Care Setting.

Authors:  Judy Kempf; Erin Buysman; Diana Brixner
Journal:  Am Health Drug Benefits       Date:  2011-09

9.  Direct medical cost of newly diagnosed stable coronary artery disease in Hong Kong.

Authors:  Vivian W Y Lee; Yat Yin Lam; Amy C M Yuen; Shuk Yan Cheung; Cheuk-Man Yu; Bryan P Y Yan
Journal:  Heart Asia       Date:  2013-01-02

Review 10.  The conundrum of detecting stable angina pectoris in the community setting.

Authors:  Mary Russell; Marie Williams; Esther May; Simon Stewart
Journal:  Nat Rev Cardiol       Date:  2009-12-22       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.